Invokana is FDA-approved to improve glycemic control in adults with type 2 diabetes mellitus in combination with diet and exercise.
Invokana is also used to lower the risk of cardiovascular death from heart attack, stroke, or heart failure in adults with type 2 diabetes mellitus with established cardiovascular disease. In addition, Invokana helps reduce the risk of end-stage kidney disease and hospitalization or death from heart problems in adults who have impaired kidney function due to type 2 diabetes mellitus.
Invokana is not effective for treating type 1 diabetes or diabetic ketoacidosis.